| Phyllis Holzworth, ARNP | |
|
3000 California Ave Sw, Seattle, WA 98116-3302 | |
| (206) 658-8048 | |
| (206) 658-8063 |
| Full Name | Phyllis Holzworth |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 3000 California Ave Sw, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013012152 | NPI | - | NPPES |
| 961586 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN00078257 (Washington) | Primary |
| 363L00000X | Nurse Practitioner | AP30001367 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Phyllis Holzworth, ARNP 905 Spruce St Ste 300, Seattle, WA 98104-2474 Ph: (206) 461-6935 | Phyllis Holzworth, ARNP 3000 California Ave Sw, Seattle, WA 98116-3302 Ph: (206) 658-8048 |
News Archive
Researchers from the University of Rochester, USA, has produced an AI-based study that analyzes the social media platform Twitter to gauge public opinions in the US surrounding SARS-CoV-2 vaccines to shed greater light on this issue.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced that Dr. David B. Weiner, Chairman of Inovio's Scientific Advisory Board, highlighted advances in electroporation-delivered SynCon™ DNA vaccines compared to other leading vaccine technologies at the AIDS Vaccine 2009 Conference being held this week in Paris, France.
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Levonorgestrel Tablets, 0.75 mg for over-the-counter use in women ages 17 and above, as well as for prescription use in women under the age of 17.
President Obama will release his overdue budget on Wednesday. It will doubtless project a reduction in the federal budget deficit-;a projection that journalists, commentators and policy makers should ignore.
The research group "Estudio de sustancias antagonistas producidas por microorganismos" (Antagonistic substances produced by microorganisms), part of the Microbiology Department of the University of Granada, has succeeded in isolating enterocin AS-48, which could have a medium-term use as food biopreservative.
› Verified 1 days ago
Mrs. Joanne Lynn Osetsky, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 550 17th Ave, Ste 110, Seattle, WA 98122 Phone: 206-320-3470 Fax: 206-320-3471 | |
Sandra K Walker, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-598-0502 Fax: 206-598-0516 | |
Ms. Jennifer Patano, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4800 Sand Point Way Ne, Ms O.7.720, Seattle, WA 98105 Phone: 206-987-8949 Fax: 206-987-8943 | |
Mrs. Dominique Michelle Well, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4715 42nd Ave Sw, Seattle, WA 98116 Phone: 206-265-3642 | |
Mrs. Susan L Holtzclaw, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Mailstop T-2108, Seattle, WA 98105 Phone: 206-987-5691 | |
Dr. Kaitlin Michelle Brasier, D.N.P., A.R.N.P., RN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1525 4th Ave, Suite 300, Seattle, WA 98101 Phone: 206-838-6856 Fax: 206-838-3085 | |
Melissa Yen-ching Lo, DNP, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-861-3396 |